Quick Answer
GeneDx Holdings Corp. reported Net Income of -$21.02 million for fiscal year 2025.
GeneDx Holdings Corp. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$21.02M | +59.8% |
| 2024 | -$52.29M | +70.3% |
| 2023 | -$175.77M | +68.0% |
| 2022 | -$548.98M | -123.7% |
| 2021 | -$245.39M | -1.7% |
| 2020 | -$241.34M | -712.5% |
| 2019 | -$29.70M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.63M | +8.1% | -170.6% |
| June 30, 2025 | $10.81M | +137.1% | +265.6% |
| March 31, 2025 | -$6.53M | +67.7% | +21.5% |
| September 30, 2024 | -$8.31M | +80.3% | +71.5% |
| June 30, 2024 | -$29.17M | +37.6% | -44.1% |
| March 31, 2024 | -$20.24M | +66.8% | +52.1% |
| September 30, 2023 | -$42.29M | +45.5% | +9.5% |
| June 30, 2023 | -$46.72M | +45.5% | +23.4% |
- GeneDx Holdings Corp. showed an increase of +59.8% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, GeneDx Holdings Corp.’s net income has grown by 29.2% (from -$29.70 million to -$21.02 million).
- The most recent figure is from GeneDx Holdings Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: